vimarsana.com
Home
Live Updates
ABVC BioPharma and its Subsidiary Receive $460M From AiBtl : vimarsana.com
ABVC BioPharma and its Subsidiary Receive $460M From AiBtl
FREMONT, CA , Jan. 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) and its subsidiary BioLite, Inc. (
Related Keywords
California ,
United States ,
Fremont ,
Stanford University ,
Delaware ,
Leeds Chow ,
Russman Jaimes ,
Uttam Patil ,
University Of California At San Francisco ,
Company Annual Report On Form ,
Straits Research ,
Sinai Medical Center ,
Biopharma Inc ,
Exchange Commission ,
Biolite Inc ,
Nasdaq ,
Aibtl Biopharma Inc ,
Aibtl Biopharma ,
Major Depressive Disorder ,
Attention Deficit Hyperactivity Disorder ,
Chief Executive Officer ,
Chief Executive Officer Russman ,
Future Market Insights ,
San Francisco ,
Cedars Sinai Medical ,
For Vitargus ,
Market Approval ,
Annual Report ,
Quarterly Reports ,
Nasdaq Abvc ,
Abvc Biopharma ,
Nc ,
vimarsana.com © 2020. All Rights Reserved.